TMED
T. Rowe Price Health Care ETF·NASDAQ
--
--(--)
--
--(--)
Key Stats
Assets Under Management
17.76MUSD
Fund Flows (1Y)
5.29MUSD
Dividend Yield
0.55%
Discount/Premium to NAV
0.04%
Shares Outstanding
600.00K
Expense Ratio
0.44%
About T. Rowe Price Health Care ETF
Issuer
T. Rowe Price Associates, Inc.
Brand
T. Rowe Price
Inception Date
Jun 11, 2025
Structure
Open-Ended Fund
Index Tracked
--
Management Style
Active
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
T. Rowe Price Associates, Inc. (IM)
Distributor
T. Rowe Price Investment Services, Inc.
TMED actively invests in securities of health care companies located mainly in the US but may also include foreign companies as well. Health care companies include a wide range such as biotechnology, pharmaceuticals, products and device providers, and health care service companies. Firms must be classified in the MSCI GICS health care sector. The fund employs a fundamental, bottom-up analysis and can invest in companies across any market capitalization using both growth and value strategies, typically focusing on 100-150 stocks. This includes the use of derivatives related to the fund's investment focus. The funds management team aims to outperform its respective sector index.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Broad-based
Strategy
Active
Geography
--
Weighting Scheme
Proprietary
Selection Criteria
Proprietary
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | -3.28% | +3.78% | +0.03% | +18.47% | +18.47% | +18.47% |
NAV Total Return | -4.40% | +2.42% | -2.70% | — | — | — |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
100.00%
Healthcare
100.00%
Asset
Region
94.1%
5.9%
Category
Ratio
North America
94.10%
Europe
5.90%
Investment Style
No data is currently available
Top 10 Holdings
Symbol
Ratio
LLY
Eli Lilly
14.86%
UNH
UnitedHealth Group
6.84%
GILD
Gilead Sciences
4.31%
ABT
Abbott Laboratories
4.22%
TMO
Thermo Fisher
3.93%
DHR
Danaher
3.12%
BDX
Becton, Dickinson
2.63%
ELAN
Elanco Animal Health
2.56%
CYTK
Cytokinetics
2.31%
MDT
Medtronic
2.23%
Top 10 Weight 47%
105 Total Holdings
Is SPY better than TMED?
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-12-23 | 2025-12-23 | 2025-12-26 | 0.162 |
How Much Does TMED Pay in Dividends?
Premium/Discount Chart
Assets Under Management
Should I buy TMED?
Fund Flows
